These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37951090)

  • 1. Calcium flux alterations in erythrocytes from sickle cell mice: The relevance of mean corpuscular volume.
    Almeida LEF; Smith ML; Kamimura S; Vogel S; Quezado ZMN
    Blood Cells Mol Dis; 2024 Jan; 104():102800. PubMed ID: 37951090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association study of erythrocyte density in sickle cell disease patients.
    Ilboudo Y; Bartolucci P; Rivera A; Sedzro JC; Beaudoin M; Trudel M; Alper SL; Brugnara C; Galactéros F; Lettre G
    Blood Cells Mol Dis; 2017 Jun; 65():60-65. PubMed ID: 28552477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual Microcirculation Specificity of Sickle Cell Patients: Morphology of the Microvascular Bed, Blood Rheology, and Local Hemodynamics.
    Sant S; Gouraud E; Boisson C; Nader E; Goparaju M; Cannas G; Gauthier A; Joly P; Renoux C; Merazga S; Hautier C; Connes P; Fenech M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel permeability characteristics of red blood cells from sickle cell patients heterozygous for HbS and HbC (HbSC genotype).
    Dalibalta S; Ellory JC; Browning JA; Wilkins RJ; Rees DC; Gibson JS
    Blood Cells Mol Dis; 2010 Jun; 45(1):46-52. PubMed ID: 20227897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model.
    Quezado ZMN; Kamimura S; Smith M; Wang X; Heaven MR; Jana S; Vogel S; Zerfas P; Combs CA; Almeida LEF; Li Q; Quezado M; Horkayne-Szakaly I; Kosinski PA; Yu S; Kapadnis U; Kung C; Dang L; Wakim P; Eaton WA; Alayash AI; Thein SL
    Blood Cells Mol Dis; 2022 Jul; 95():102660. PubMed ID: 35366607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
    Schroeder P; Fulzele K; Forsyth S; Ribadeneira MD; Guichard S; Wilker E; Marshall CG; Drake A; Fessler R; Konstantinidis DG; Seu KG; Kalfa TA
    J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole blood viscosity and red blood cell adhesion: Potential biomarkers for targeted and curative therapies in sickle cell disease.
    Kucukal E; Man Y; Hill A; Liu S; Bode A; An R; Kadambi J; Little JA; Gurkan UA
    Am J Hematol; 2020 Nov; 95(11):1246-1256. PubMed ID: 32656816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice.
    Taylor CM; Kasztan M; Sedaka R; Molina PA; Dunaway LS; Pollock JS; Pollock DM
    Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R630-R640. PubMed ID: 33624556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between haematological parameters and sickle cell genotypes in children with Plasmodium falciparum malaria resident in Kisumu County in Western Kenya.
    Kosiyo P; Otieno W; Gitaka J; Munde EO; Ouma C
    BMC Infect Dis; 2020 Nov; 20(1):887. PubMed ID: 33238928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.
    Faes C; Ilich A; Sotiaux A; Sparkenbaugh EM; Henderson MW; Buczek L; Beckman JD; Ellsworth P; Noubouossie DF; Bhoopat L; Piegore M; Renoux C; Bergmeier W; Park Y; Ataga KI; Cooley B; Wolberg AS; Key NS; Pawlinski R
    Blood; 2019 Jun; 133(23):2529-2541. PubMed ID: 30952675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia activates a Ca2+-permeable cation conductance sensitive to carbon monoxide and to GsMTx-4 in human and mouse sickle erythrocytes.
    Vandorpe DH; Xu C; Shmukler BE; Otterbein LE; Trudel M; Sachs F; Gottlieb PA; Brugnara C; Alper SL
    PLoS One; 2010 Jan; 5(1):e8732. PubMed ID: 20090940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.
    Nyffenegger N; Zennadi R; Kalleda N; Flace A; Ingoglia G; Buzzi RM; Doucerain C; Buehler PW; Schaer DJ; Dürrenberger F; Manolova V
    Blood; 2022 Aug; 140(7):769-781. PubMed ID: 35714304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration.
    Kaul DK; Liu XD
    Clin Hemorheol Microcirc; 1999; 21(2):125-35. PubMed ID: 10599596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin.
    Reilly MP; Chomo MJ; Obata K; Asakura T
    Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell lactate transport in sickle disease and sickle cell trait.
    Pattillo RE; Gladden LB
    J Appl Physiol (1985); 2005 Sep; 99(3):822-7. PubMed ID: 15890755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized microfluidic assessment of red blood cell-mediated microcapillary occlusion: Association with clinical phenotype and hydroxyurea responsiveness in sickle cell disease.
    Man Y; Kucukal E; An R; Bode A; Little JA; Gurkan UA
    Microcirculation; 2021 Feb; 28(2):e12662. PubMed ID: 33025653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-uniformity of intracellular polymer formation in sickle erythrocytes: possible correlation with severity of hemolytic anemia.
    Noguchi CT; Schechter AN
    Am J Pediatr Hematol Oncol; 1984; 6(1):46-50. PubMed ID: 6711762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo measurement of RBC survival in patients with sickle cell disease before or after hematopoietic stem cell transplantation.
    Leonard AK; Furstenau D; Inam Z; Luckett C; Chu R; Demirci S; Essawi K; Gudmundsdottir B; Hinds M; DiNicola J; Li Q; Eaton WA; Cellmer T; Wang X; Thein SL; Macari ER; VanNest S; Hsieh MM; Bonner M; Pierciey FJ; Tisdale JF
    Blood Adv; 2024 Apr; 8(7):1806-1816. PubMed ID: 38181784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and rheological factors contributing to sickle cell microvascular occlusion.
    Kurantsin-Mills J; Lessin LS
    Blood Cells; 1986; 12(1):249-70. PubMed ID: 3790735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.